Ascentage Pharma Group International (AAPG) Long-Term Investments: 2023-2025

  • Ascentage Pharma Group International's Long-Term Investments was N/A to $4.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.5 million, marking a year-over-year change of. This contributed to the annual value of $4.5 million for FY2024, which is 86.34% up from last year.
  • As of Q2 2025, Ascentage Pharma Group International's Long-Term Investments stood at $4.5 million, which was up 0.92% from $4.5 million recorded in Q4 2024.
  • In the past 5 years, Ascentage Pharma Group International's Long-Term Investments ranged from a high of $4.5 million in Q2 2025 and a low of $2.4 million during Q4 2023.
  • Over the past 3 years, Ascentage Pharma Group International's median Long-Term Investments value was $4.5 million (recorded in 2024), while the average stood at $3.8 million.
  • Data for Ascentage Pharma Group International's Long-Term Investments shows a peak YoY skyrocketed of 89.85% (in 2024) over the last 5 years.
  • Over the past 3 years, Ascentage Pharma Group International's Long-Term Investments (Quarterly) stood at $2.4 million in 2023, then spiked by 89.85% to $4.5 million in 2024, then reached $4.5 million in 2025.
  • Its Long-Term Investments was $4.5 million in Q2 2025, compared to $4.5 million in Q4 2024 and $2.4 million in Q4 2023.